2018

04 December Half Yearly Report
Interim Results for the six months ended 30 September 2018
05 November Realignment of Bond Repayments to enable further growth to be achieved
23 October Trading Update and Notice of Results
18 October Collagen to present at Biotech and Money's Inv€$tival Showcase
26 September Holding(s) in Company
25 September Director/PDMR Dealing
19 September Director/PDMR Dealing
03 September Director/PDMR Dealing
03 September Board Appointments
03 September Executive Share Options Alignment
24 August Director/PDMR Dealing
22 August Result of AGM
22 August AGM Statement
Delivering on our growth strategy
21 August Appointment of Distributors in China
25 July Posting of Annual Report and Notice of AGM
10 July Final Results for the year ended 31 March 2018
13 June Notice of results for the year ended 31 March 2018
Analyst and investor briefing
08 May Collagen Solutions to Exhibit at 18th ESSKA Conference
"European Society of Sports Traumatology, Knee Surgery and Arthroscopy"
Dates: 9-12 May, SEEC, Glasgow
03 May Director / PDMR Dealing
11 April Director / PDMR Dealing
10 April Appointment of Chief Business Officer
06 April Director / PDMR Dealing
04 April Trading Update
28 March Collagen Solutions Proposed Restructuring of New Zealand Operations to Pursue Tissue Opportunities
01 March Collagen Solutions to Present at Canaccord Genuity Musculoskeletal Conference & Exhibit at American Academy of Orthopaedic Surgeons Conference
26 February Hardman & Co Res: Nearing first proprietary product
22 February Director/PDMR Shareholding
21 February Positive Eight-Year Results of ChondroMimetic® Cartilage Repair Clinical Study
15 February China Update
06 February London Investor Symposium
Monday 26 February 2018